You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Incurable Platinum Refractory Germ Cell Tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Germ Cell Tumors, Testicular Tumors, Non Seminomatous Germ Cell Tumors Trial in Indianapolis, Philadelphia (Pembrolizumab)

Terminated
Has Results
  • Germ Cell Neoplasms
  • +6 more
  • Indianapolis, Indiana
  • +1 more
Jul 7, 2022

Incurable Platinum Refractory Germ Cell Tumors, Tumors Trial in Indianapolis, New York, Philadelphia (ASP1650)

Completed
Has Results
  • Incurable Platinum Refractory Germ Cell Tumors
  • Tumors
  • Indianapolis, Indiana
  • +2 more
Nov 30, 2021

Germ Cell Tumor, Seminoma, Non-seminomatous Germ Cell Tumor Trial in Indianapolis (Cabozantinib)

Recruiting
  • Germ Cell Tumor
  • +3 more
  • Indianapolis, Indiana
    Indiana University Melvin & Bren Simon Cancer Center
Nov 16, 2022

Germ Cell Tumor, Nonseminomatous Germ Cell Tumor, Seminoma Trial in United States (Durvalumab, Tremelimumab)

Active, not recruiting
  • Germ Cell Tumor
  • +5 more
  • Basking Ridge, New Jersey
  • +6 more
May 2, 2022

CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)

Active, not recruiting
  • Central Nervous System Tumor, Pediatric
  • +8 more
  • EGFR806-specific chimeric antigen receptor (CAR) T cell
  • Seattle, Washington
    Seattle Children's Hospital
Jan 18, 2023

CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)

Recruiting
  • Central Nervous System Tumor, Pediatric
  • +8 more
  • HER2-specific chimeric antigen receptor (CAR) T cell
  • Seattle, Washington
    Seattle Children's Hospital
Dec 14, 2022

Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Canada, United States (Onivyde, Talazoparib,

Recruiting
  • Recurrent Solid Tumor
  • +21 more
  • Palo Alto, California
  • +8 more
Jun 7, 2022

Pediatric Cancer, Solid Tumors, Rhabdomyosarcoma Trial in Washington (Magnetic resonance high intensity focused ultrasound,

Recruiting
  • Pediatric Cancer
  • +9 more
  • Magnetic resonance high intensity focused ultrasound
  • Lyso-thermosensitive liposomal doxorubicin
  • Washington, District of Columbia
    Children's National Medical Center
Dec 10, 2021

Malignant Abdominal Tumor, Malignant Pelvic Tumor, Recurrent Colon Carcinoma Trial in Rochester (Cisplatin, Cytoreductive

Recruiting
  • Malignant Abdominal Neoplasm
  • +26 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023

Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Valhalla (Vorinostat)

Recruiting
  • Ewing Sarcoma
  • +5 more
  • Valhalla, New York
    New York Medical College
Oct 24, 2022

CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

Recruiting
  • Central Nervous System Tumor
  • +10 more
  • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
  • Seattle, Washington
    Seattle Children's Hospital
Dec 14, 2022

Ex Vivo Drug Sensitivity Testing and Mutation Profiling

Completed
  • Recurrent Childhood Acute Myeloid Leukemia
  • +13 more
    • Miami, Florida
      Nicklaus Children's Hospital
    Jan 18, 2023

    Relapsed Pediatric Solid Tumors, Refractory Pediatric Solid Tumors, Rhabdomyosarcoma Trial in Washington, Cincinnati (Magnetic

    Active, not recruiting
    • Relapsed Pediatric Solid Tumors
    • +9 more
    • Magnetic Resonance High Intensity Focused Ultrasound
    • Washington, District of Columbia
    • +1 more
    Jan 21, 2022

    Small Cell Carcinoma, NSCLC, Neuroendocrine Tumors Trial in United States (RRx-001, Cisplatin, Etoposide)

    Active, not recruiting
    • Small Cell Carcinoma
    • +3 more
    • Palo Alto, California
    • +9 more
    May 12, 2022

    Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

    Recruiting
    • Pediatric Solid Tumor
    • +15 more
    • second generation 4-1BBζ EGFR806-EGFRt
    • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
    • Seattle, Washington
      Seattle Children's Hospital
    May 2, 2022

    Germ Cell Tumors, Measurable Disease Trial in Milano (Pazopanib)

    Completed
    • Germ Cell Tumors
    • Measurable Disease
    • Milano, Mi, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori
    May 12, 2021

    Germ Cell Tumor Trial in Milano (Durvalumab, Tremelimumab)

    Terminated
    • Germ Cell Tumor
    • Milano, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori
    May 12, 2021

    Solid Tumors, Soft Tissue Sarcoma, Ewing Sarcoma Trial (Magnetic Resonance-Guided High Intensity Focused Ultrasound,

    Not yet recruiting
    • Solid Tumors
    • +8 more
    • Magnetic Resonance-Guided High Intensity Focused Ultrasound
    • Lyso-thermosensitive Liposomal Doxorubicin
    • (no location specified)
    Mar 10, 2022

    Non-CNS Germ Cell Tumors (Seminomas and Nonseminomas) Trial in France, United Kingdom, United States (Tivantinib (ARQ 197))

    Terminated
    Has Results
    • Non-CNS Germ Cell Tumors (Seminomas and Nonseminomas)
    • Tivantinib (ARQ 197)
    • Los Angeles, California
    • +9 more
    Mar 12, 2021

    Germ Cell Tumor Trial in Minneapolis (Brentuximab Vedotin, Bevacizumab)

    Terminated
    Has Results
    • Germ Cell Tumor
    • Minneapolis, Minnesota
      University of Minnesota
    Nov 12, 2020

    Genitourinary Cancer, Adrenocortical Carcinoma, Non-urothelial Bladder Trial in United States (Ipilimumab, Nivolumab)

    Recruiting
    • Genitourinary Cancer
    • +7 more
    • La Jolla, California
    • +5 more
    Jul 5, 2022

    CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Not Otherwise Specified, CNS Ganglioneuroblastoma Trial in

    Active, not recruiting
    Has Results
    • Central Nervous System Embryonal Tumor With Rhabdoid Features
    • +14 more
    • Birmingham, Alabama
    • +23 more
    Oct 7, 2022

    Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +31 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Birmingham, Alabama
    • +118 more
    Jan 27, 2023

    Germ Cell Tumors Trial in France (Paclitaxel, Ifosfamide, Carboplatine)

    Completed
    • Germ Cell Tumors
    • Angers, France
    • +11 more
    Jan 11, 2021

    Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +35 more
    • Birmingham, Alabama
    • +108 more
    Oct 19, 2022